(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)-N-((1-phenethyl-1H-1,2,3-triazol-4-yl)methyl)cyclohex-1-ene-1-carboxamide

ID: ALA4463508

Chembl Id: CHEMBL4463508

PubChem CID: 155530207

Max Phase: Preclinical

Molecular Formula: C25H36N6O3

Molecular Weight: 468.60

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)NCc2cn(CCc3ccccc3)nn2)C[C@H](N)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C25H36N6O3/c1-4-21(5-2)34-23-14-19(13-22(26)24(23)28-17(3)32)25(33)27-15-20-16-31(30-29-20)12-11-18-9-7-6-8-10-18/h6-10,14,16,21-24H,4-5,11-13,15,26H2,1-3H3,(H,27,33)(H,28,32)/t22-,23+,24+/m0/s1

Standard InChI Key:  UVQVYAJDYQKKTD-RBZQAINGSA-N

Alternative Forms

  1. Parent:

    ALA4463508

    ---

Associated Targets(non-human)

NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (2284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.60Molecular Weight (Monoisotopic): 468.2849AlogP: 1.87#Rotatable Bonds: 11
Polar Surface Area: 124.16Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.61CX Basic pKa: 9.11CX LogP: 1.71CX LogD: 0.01
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.46Np Likeness Score: -0.40

References

1. Ju H, Xiu S, Ding X, Shang M, Jia R, Huang B, Zhan P, Liu X..  (2020)  Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.,  187  [PMID:31835169] [10.1016/j.ejmech.2019.111940]

Source